Last $0.96 USD
Change Today -0.015 / -1.54%
Volume 10.0K
DYAI On Other Exchanges
Symbol
Exchange
OTC US
As of 11:28 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

dyadic international inc (DYAI) Key Developments

Dyadic International Appoints Michael Tarnok as Chairman of the Board of Directors

Dyadic International, Inc. announced the appointment of Michael Tarnok as the company's Chairman of the Board of Directors. Mr. Tarnok will continue to serve on the company's audit and compensation committees. Mr. Tarnok has extensive experience in the pharmaceutical industry across many key areas including finance, operations and marketing. He is also the current Chairman and former Interim CEO of Keryx Biopharmaceuticals, Inc.

Dyadic International, Inc. Extends Debt Maturity Date on Note Payable

Dyadic International, Inc. announced that it has entered into an agreement to extend the maturity date of the $1.4 million non-convertible 9.5% note payable to January 1, 2016. All other terms and conditions of the debt remain unchanged. The company has entered into agreements with all of its outstanding promissory note holders to extend their maturity dates to January 1, 2016.

Dyadic International, Inc. Presents at Pacific Rim Summit 2014, Dec-08-2014 02:30 PM

Dyadic International, Inc. Presents at Pacific Rim Summit 2014, Dec-08-2014 02:30 PM. Venue: San Diego, California, United States. Speakers: Danai Eric Brooks, Chief Operating Officer and Executive Vice President.

Dyadic International, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Dyadic International, Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the nine months, the company reported total revenue of $9,832,740 against $13,023,024 a year ago. Loss from operations was $3,806,772 against income from operations of $978,035 a year ago. Loss before provision for income taxes was $4,295,444 against income before provision for income taxes of $158,647 a year ago. Net loss was $4,295,444 against net income of $120,647 a year ago. Basic and diluted net loss per common share was $0.13. Net cash used in operating activities was $5,352,323 against net cash provided by operating activities of $4,509,167 a year ago. Purchases of fixed assets were $191,161 against $147,986 a year ago. The increase in sales for the period was driven by growth in the animal nutrition, brewing, starch and alcohol markets. The decrease in total revenue is primarily due to licensing revenue of $700,000 versus $5.0 million in the first nine months of 2013 reflecting the BASF upfront license fee. For the quarter, the company reported total revenue of $3,786,025 against $3,460,418 a year ago. Loss from operations was $881,209 against $1,258,674 a year ago. Loss before provision for income taxes was $1,047,592 against $1,741,437 a year ago. Net loss was $1,047,592 against $1,741,437 a year ago. Diluted net loss per common share was $0.03 against $0.05 a year ago.

Dyadic International, Inc. Presents at Drexel Hamilton Micro-Cap Investor Forum 2014, Nov-13-2014 08:30 AM

Dyadic International, Inc. Presents at Drexel Hamilton Micro-Cap Investor Forum 2014, Nov-13-2014 08:30 AM. Venue: Drexel Hamilton's offices, 77 Water Street Downtown, New York, New York, United States. Speakers: Danai Eric Brooks, Chief Operating Officer and Executive Vice President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DYAI:US $0.96 USD -0.015

DYAI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
EI du Pont de Nemours & Co $77.82 USD -0.67
Koninklijke DSM NV €49.33 EUR -0.56
Lonza Group AG SFr.117.50 CHF -0.80
Merck KGaA €94.56 EUR -0.80
Novozymes A/S kr317.10 DKK -5.00
View Industry Companies
 

Industry Analysis

DYAI

Industry Average

Valuation DYAI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DYADIC INTERNATIONAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.